Ryosuke Takano

Hamamatsu, Japan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 16 publications

Charcoal gum-associated pseudomelanosis ilei with aluminum and titanium enrichment on elemental analysis.

Charcoal gum-associated pseudomelanosis ilei with aluminum and titanium enrichment on elemental analysis.

Journal: Gastrointestinal endoscopy

Published: February 09, 2026

Vedolizumab-steroid combination therapy improves long-term prognosis in patients with ulcerative colitis.

Vedolizumab-steroid combination therapy improves long-term prognosis in patients with ulcerative colitis.

Journal: BMC gastroenterology

Published: December 14, 2024

Utility of abdominal ultrasonography in the management of ulcerative colitis:proposal of a new scoring system

Utility of abdominal ultrasonography in the management of ulcerative colitis:proposal of a new scoring system

Journal: Nihon Shokakibyo Gakkai zasshi = The Japanese journal of gastro-enterology

Published: August 13, 2024

Therapeutic monitoring of adalimumab at non-trough levels in patients with inflammatory bowel disease.

Therapeutic monitoring of adalimumab at non-trough levels in patients with inflammatory bowel disease.

Journal: PloS one

Published: April 21, 2021

Usefulness of the capsule endoscopy Crohn's disease activity index in assessing the necessity of early additional treatment in patients with Crohn's disease in clinical remission.

Usefulness of the capsule endoscopy Crohn's disease activity index in assessing the necessity of early additional treatment in patients with Crohn's disease in clinical remission.

Journal: Medicine

Published: January 27, 2021

Highly Bioavailable Curcumin Derivative Ameliorates Crohn's Disease Symptoms: A Randomized, Double-Blind, Multicenter Study.

Highly Bioavailable Curcumin Derivative Ameliorates Crohn's Disease Symptoms: A Randomized, Double-Blind, Multicenter Study.

Journal: Journal of Crohn's & colitis

Published: May 16, 2020

Effect of ulcerative colitis duration on the usefulness of immunochemical fecal occult blood test result as a disease activity biomarker.

Effect of ulcerative colitis duration on the usefulness of immunochemical fecal occult blood test result as a disease activity biomarker.

Journal: International journal of colorectal disease

Published: May 14, 2020

Prostaglandin E-major urinary metabolite versus fecal immunochemical occult blood test as a biomarker for patient with ulcerative colitis.

Prostaglandin E-major urinary metabolite versus fecal immunochemical occult blood test as a biomarker for patient with ulcerative colitis.

Journal: BMC gastroenterology

Published: October 03, 2019

Correction: A multicenter retrospective study aiming to identify patients who respond well to adsorptive granulomonocytapheresis in moderately to severely active ulcerative colitis.

Correction: A multicenter retrospective study aiming to identify patients who respond well to adsorptive granulomonocytapheresis in moderately to severely active ulcerative colitis.

Journal: Clinical and translational gastroenterology

Published: November 16, 2018

Correction: A multicenter retrospective study aiming to identify patients who respond well to adsorptive granulomonocytapheresis in moderately to severely active ulcerative colitis.

Correction: A multicenter retrospective study aiming to identify patients who respond well to adsorptive granulomonocytapheresis in moderately to severely active ulcerative colitis.

Journal: Clinical and translational gastroenterology

Published: October 13, 2018

Evaluating mucosal healing using colon capsule endoscopy predicts outcome in patients with ulcerative colitis in clinical remission.

Evaluating mucosal healing using colon capsule endoscopy predicts outcome in patients with ulcerative colitis in clinical remission.

Journal: World journal of clinical cases

Published: August 24, 2018

Assessment of Long-Term Efficacy and Safety of Adalimumab in Patients with Ulcerative Colitis: Results from a 6-Year Real-World Clinical Practice.

Assessment of Long-Term Efficacy and Safety of Adalimumab in Patients with Ulcerative Colitis: Results from a 6-Year Real-World Clinical Practice.

Journal: Digestive diseases (Basel, Switzerland)

Published: March 21, 2018

Showing 1-12 of 16

Last Updated: 09/26/2026